HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FTC departure

This article was originally published in The Rose Sheet

Executive Summary

J. Howard Beales, III, director of the Federal Trade Commission's Bureau of Consumer Protection, will leave his post on Aug. 6 to return to academia, agency announces July 16. Beales has been director since mid-2001. Under his leadership, the agency filed 258 federal district court cases and obtained orders for about $1.3 bil. in consumer redress, FTC notes. He assisted in the creation and implementation of the National Do Not Call Registry launched late last year, and more recently urged retailers and manufacturers to consider consumer privacy concerns in implementing radio frequency identification technology (1"The Rose Sheet" June 28, 2004, p. 10). Deputy Director Lydia Parnes replaces Beales as acting director. Parnes has been with the FTC since 1981, and was appointed to her current role in 1992...

You may also be interested in...

RFID Implementation Must Ensure Consumer Privacy – FTC’s Beales

Consumer privacy concerns must be addressed by retailers and manufacturers as they implement radio frequency identification technology, Federal Trade Commission Bureau of Consumer Protection Director J. Howard Beales said during an FTC RFID workshop June 21 in Washington, D.C

DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss

The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.

Could ICER Outreach To US FDA Lead To Better Cost Effectiveness Analyses?

To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts